Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies

Clinical trial NCT06787482 · RECRUITING

Trial details

NCT number: NCT06787482
Sponsor: Ace Cells Lab Limited
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Retinitis Pigmentosa (RP)Age Related Macular Degeneration Diabetic Retinopathy

Start date: 2024-11-12
Primary completion: 2025-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.